Wolverine Stack
A research blend combining BPC-157 and TB-500, metered from a single 3 mL pen cartridge.
The Wolverine Stack is a dual-peptide research formulation containing BPC-157 (10mg) and TB-500 (10mg) — 20mg total — supplied as a pre-configured laboratory format. Standardising the two peptides in one vial gives researchers a consistent composition and removes variability from solution preparation, supporting reproducible handling and uniform exposure across non-clinical workflows.
Research use only. The Wolverine Stack is supplied strictly for in-vitro laboratory research. This page does not describe dosing, administration, or use in humans or animals, and makes no therapeutic claims.
The two components
- BPC-157 — studied as a probe for peptide-mediated signalling and cellular-response mechanisms.
- TB-500 — a thymosin beta-4 fragment studied for actin dynamics and cytoskeletal organisation.
Why study them as a set
The combined system lets researchers examine dual-peptide interactions and observe coordinated or independent pathway activity within a single solution matrix — for example, comparing cellular signalling and structural responses side by side under standardised conditions.
Typical research applications include cellular signalling and receptor-interaction studies, cytoskeletal modelling related to actin dynamics, peptide-stability analysis, and combined-peptide interaction studies.
How it is supplied
Supplied as a vial with a Certificate of Analysis, stored refrigerated at 2–8°C. The components are also available individually: BPC-157 and TB-500.
Related reading
- Components
- BPC-157 + TB-500
- Protocol dose
- 0.67 mg per day
1× daily
- Pen clicks per dose
- 10 clicks (0.1 mL)
- Concentration
- 6.7 mg/mL (≈20.1 mg per 3 mL pen)
- Frequency
- 1× daily
Reported research parameters drawn from the cited literature — provided for reference only. These are not dosing, usage, or medical recommendations.